RICHARD JOSEPH BERTZ
Pharmacy in Kenosha, WI
License number
Pennsylvania RP035788R
Category
Pharmacy
Type
Pharmacist
Address
Address
2
Kenosha, WI 53142
Pennsylvania
Pennsylvania
Personal information
See more information about RICHARD JOSEPH BERTZ at radaris.comName
Address
Phone
511 Clydesdale Dr, New Hope, PA 18938
5828 80Th Pl, Kenosha, WI 53142
822 Imperial Dr, Lancaster, PA 17601
Southampton, PA
22 County Road G, Saint Cloud, WI 53079
Professional information
Method For Improving Pharmacokinetics
US Patent:
6703403, Mar 9, 2004
Filed:
Sep 20, 2001
Appl. No.:
09/957171
Inventors:
Daniel W. Norbeck - Crystal Lake IL
Dale J. Kempf - Libertyville IL
John M. Leonard - Lake Bluff IL
Richard J. Bertz - Kenosha WI
Dale J. Kempf - Libertyville IL
John M. Leonard - Lake Bluff IL
Richard J. Bertz - Kenosha WI
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A01N 4342
US Classification:
514300, 514365, 435184, 548204, 548205
Abstract:
A method is disclosed for improving the pharmacokinetics of a drug which is metabolized by cytochrome P450 monooxygenase.
Method For Treating A Disease, Disorder Or Adverse Effect Caused By An Elevated Serum Concentration Of An Ugt1A1 Substrate
US Patent:
2004019, Sep 30, 2004
Filed:
Mar 24, 2003
Appl. No.:
10/395772
Inventors:
Dale Kempf - Libertyville IL, US
Richard Bertz - Kenosha WI, US
Jeffrey Waring - Franklin WI, US
Richard Bertz - Kenosha WI, US
Jeffrey Waring - Franklin WI, US
International Classification:
A61K031/7056
US Classification:
514/043000
Abstract:
The present invention is directed to a method for inducing UGT1A1 isoform expression for treatment of a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate comprising the step of administering to a subject an effective amount of ritonavir. In particular, the present invention is directed to a method of treating unconjugated hyperbilirubinemia by UGT1A1 induction comprising the step of administering to a subject an effective amount of ritonavir.
Method For Treating A Disease, Disorder Or Adverse Effect Caused By An Elevated Serum Concentration Of An Ugt1A1 Substrate
US Patent:
7320961, Jan 22, 2008
Filed:
Mar 18, 2004
Appl. No.:
10/802829
Inventors:
Dale J. Kempf - Libertyville IL, US
Richard J. Bertz - Kenosha WI, US
Jeffrey F. Waring - Franklin WI, US
Richard J. Bertz - Kenosha WI, US
Jeffrey F. Waring - Franklin WI, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 31/425, A61K 38/00
US Classification:
514 19, 514365
Abstract:
The present invention is directed to a method for inducing UGT1A1 isoform expression for treatment of a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate comprising the step of administering to a subject an effective amount of ritonavir. In particular, the present invention is directed to a method of treating unconjugated hyperbilirubinemia by UGT1A1 induction comprising the step of administering to a subject an effective amount of ritonavir.
Method For Treating A Disease, Disorder Or Adverse Effect Caused By An Elevated Serum Concentration Of An Ugt1A1 Substrate
US Patent:
7547678, Jun 16, 2009
Filed:
Jan 15, 2008
Appl. No.:
12/008964
Inventors:
Dale J. Kempf - Libertyville IL, US
Richard J. Bertz - Kenosha WI, US
Jeffrey F. Waring - Franklin WI, US
Richard J. Bertz - Kenosha WI, US
Jeffrey F. Waring - Franklin WI, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 38/00, A61K 31/425
US Classification:
514 19, 514365
Abstract:
The present invention is directed to a method for inducing UGT1A1 isoform expression for treatment of a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate comprising the step of administering to a subject an effective amount of ritonavir. In particular, the present invention is directed to a method of treating unconjugated hyperbilirubinemia by UGT1A1 induction comprising the step of administering to a subject an effective amount of ritonavir.
Method For Improving Pharmacokinetics
US Patent:
6037157, Mar 14, 2000
Filed:
Jun 26, 1996
Appl. No.:
8/687774
Inventors:
Daniel W. Norbeck - Crystal Lake IL
Dale J. Kempf - Libertyville IL
John M. Leonard - Lake Bluff IL
Richard J. Bertz - Kenosha WI
Dale J. Kempf - Libertyville IL
John M. Leonard - Lake Bluff IL
Richard J. Bertz - Kenosha WI
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C12N 999, C07D27728
US Classification:
435184
Abstract:
A method is disclosed for improving the pharmacokinetics of a drug which is metabolized by cytochrome P450 monooxygenase.